The Europe home care market was valued at USD 84 billion in 2019 and projected to grow at a CAGR of 7.6% from forecast period 2020 to 2027.
The growing geriatric population in the region coupled with the rising incidence of chronic diseases is the key factor driving the market for home care in the region. In addition, advancements in medical devices, pharmaceuticals, and services and innovations in technology have also made home care solutions affordable for people that are homebound and prefer medical care in the comfort of their homes. Furthermore, increasing awareness about home care services and the launch of new devices for treating various conditions at home is another major factor propelling the market growth.
The services segment accounted for a revenue share of 84.1% in 2019. This is attributed to a rise in the aging population in the region and the growing demand for home-based care. The equipment segment is further segmented into therapeutic, diagnostic, and mobility assistance equipment. Therapeutic equipment dominated the market for home care in Europe in 2019. However, the diagnostic equipment segment is anticipated to witness significant growth over the forecast period. Technologically advanced products that enable accurate and timely diagnoses such as strapless heart rate monitors, iPhone heart-rate monitors, and TQR heart rate watches are likely to propel segment growth.
The market by services is segmented into skilled home care and unskilled home care. Skilled home care services are provided by healthcare professionals. The aging population suffering from diseases, such as diabetes or cardiovascular disorders seeking medical assistance is driving the market. Furthermore, the increasing prevalence of lifestyle diseases has increased the need for continuous and coordinated care services for home-bound patients recovering from acute injury or illness. Moreover, skilled nursing services avoid unnecessary hospital stays for patients and family caregivers and reduce significant medical expenditure by providing the same quality of care at a reduced cost.
Among the European countries, Germany held the largest market share of 24.1% in 2019 attributed to the fastest growth rate of the aging population and favorable universal healthcare coverage system. The growing geriatric population in developed economies such as Germany, the U.K., France, and Italy coupled with the presence of high untapped opportunities in Eastern Europe are some factors expected to drive the market during the forecast period. Moreover, changes in the social and demographic structure in Europe are also likely to spur the demand for medical assistance at home.
Some of the prominent players in the Europe home care market include:
Market Segmentation
Component Outlook
Equipment
Therapeutic
Diagnostic
Mobility Assist
Services
Skilled Nursing Services
Unskilled Nursing Services
Regional Outlook
Europe
The U.K.
Germany
France
Italy
Spain
Russia
Portugal
Switzerland
Belgium
Netherlands
Rest of Europe
Table of Contents
Chapter 1 Research Objective
1.1 Objectives
1.1.1 Objective - 1
1.1.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Component
2.3 Competition Outlook
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Lineage Outlook
3.2.1 Parent Market Outlook
3.2.2 Related/Ancillary Market Outlook
3.3 Market Dynamics
3.3.1 MARKET DRIVER ANALYSIS
3.3.1.1 Cost-effective alternatives enabled by advancements in technology
3.3.1.2 Growing geriatric population
3.3.1.3 Shift from communicable to lifestyle diseases
3.3.2 MARKET RESTRAINT ANALYSIS
3.3.2.1 Shortage of skilled healthcare staff
3.4 Business Environment Analysis tools
3.4.1 SWOT Analysis, by PESTel
3.4.1.1 Political & legal landscape
3.4.1.2 Economic landscape
3.4.1.3 Technology & social landscape
3.4.2 Porter’s five forces analysis
3.4.2.1 Competitive rivalry: High
3.4.2.2 Threat of new entrants
3.4.2.3 Bargaining power of buyers
3.4.2.4 Bargaining power of suppliers
3.4.2.5 Threat of substitutes
3.5 Penetration & Growth Prospect Mapping
Chapter 4 Europe Home Care Market: Component Analysis
4.1 Europe Home Care Component Market Share Analysis, 2019 & 2027
4.2 Patient transition rate from Inpatient to Outpatient
4.3 Equipment
4.3.1 Equipment market, 2016 - 2027 (USD Million)
4.3.2 Therapeutic
4.3.2.1 Therapeutic market, 2016 - 2027 (USD Million)
4.3.3 Diagnostics
4.3.3.1 Diagnostics market, 2016 - 2027 (USD Million)
4.3.4 Mobility assist equipment
4.3.4.1 Mobility assist equipment market, 2016 - 2027 (USD Million)
4.4 Services
4.4.1 Services market, 2016 - 2027 (USD Million)
4.4.2 Skilled Nursing Services
4.4.2.1 Skilled nursing services market, 2016 - 2027 (USD Million)
4.4.3 Unskilled Nursing Services
4.4.3.1 Unskilled nursing services market, 2016 - 2027 (USD Million)
Chapter 5 Europe Home Care Market: Regional Analysis
5.1 Europe Home Care Regional Market Share Analysis, 2019 & 2027
5.1.1 Europe home care market, 2016 - 2027 (USD Million)
5.1.2 The U.K.
5.1.2.1 Reimbursement scenario
5.1.2.2 The U.K. home care market, 2016 - 2027 (USD Million)
5.1.3 Germany
5.1.3.1 Reimbursement scenario
5.1.3.2 Germany home care market, 2016 - 2027 (USD Million)
5.1.4 France
5.1.4.1 Reimbursement scenario
5.1.4.2 France home care market, 2016 - 2027 (USD Million)
5.1.5 Italy
5.1.5.1 Reimbursement scenario
5.1.5.2 Italy home care market, 2016 - 2027 (USD Million)
5.1.6 Spain
5.1.6.1 Reimbursement scenario
5.1.6.2 Spain home care market, 2016 - 2027 (USD Million)
5.1.7 Russia
5.1.7.1 Reimbursement scenario
5.1.7.2 Russia home care market, 2016 - 2027 (USD Million)
5.1.8 Portugal
5.1.8.1 Reimbursement scenario
5.1.8.2 Portugal home care market, 2016 - 2027 (USD Million)
5.1.9 Switzerland
5.1.9.1 Reimbursement scenario
5.1.9.2 Switzerland home care market, 2016 - 2027 (USD Million)
5.1.10 Belgium
5.1.10.1 Reimbursement scenario
5.1.10.2 Belgium home care market, 2016 - 2027 (USD Million)
5.1.11 Netherlands
5.1.11.1 Reimbursement scenario
5.1.11.2 Netherlands home care market, 2016 - 2027 (USD Million)
5.1.12 Rest of Europe
5.1.12.1 Reimbursement scenario
5.1.12.2 Rest of Europe home care market, 2016 - 2027 (USD Million)
Chapter 6 Competitive Analysis
6.1 Recent Developments & Impact Analysis, by Key Market Participants
6.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, Emerging Players
6.3 Company market position analysis, by supplier/manufacturer (Product portfolio, market presence, strategic initiatives, employee strength
6.4 Company market position analysis, by service provider (Service portfolio, market presence, strategic initiatives, employee strength)
6.5 Key Company Profiles
6.5.1 By supplier/manufacturer
6.5.1.1 Koninklijke Philips N.V.
6.5.1.1.1 Company overview
6.5.1.1.2 Financial performance
6.5.1.1.3 Product benchmarking
6.5.1.1.4 Strategic initiatives
6.5.1.1.5 SWOT analysis
6.5.1.2 GE Healthcare
6.5.1.2.1 Company overview
6.5.1.2.2 Financial performance
6.5.1.2.3 Product benchmarking
6.5.1.2.4 Strategic initiatives
6.5.1.2.5 SWOT analysis
6.5.1.3 B. Braun Melsungen AG
6.5.1.3.1 Company overview
6.5.1.3.2 Financial performance
6.5.1.3.3 Product benchmarking
6.5.1.3.4 Strategic initiatives
6.5.1.3.5 SWOT analysis
6.5.1.4 Sunrise Medical
6.5.1.4.1 Company overview
6.5.1.4.2 Financial performance
6.5.1.4.3 Product benchmarking
6.5.1.4.4 Strategic initiatives
6.5.1.4.5 SWOT analysis
6.5.1.5 Medtronic PLC
6.5.1.5.1 Company overview
6.5.1.5.2 Financial performance
6.5.1.5.3 Product benchmarking
6.5.1.5.4 Strategic initiatives
6.5.1.5.5 SWOT analysis
6.5.1.6 Fresenius Kabi AG.
6.5.1.6.1 Company overview
6.5.1.6.2 Financial performance
6.5.1.6.3 Product benchmarking
6.5.1.6.4 Strategic initiatives
6.5.1.6.5 SWOT analysis
6.5.1.7 Bayer HealthCare
6.5.1.7.1 Company overview
6.5.1.7.2 Financial performance
6.5.1.7.3 Product benchmarking
6.5.1.7.4 Strategic initiatives
6.5.1.7.5 SWOT analysis
6.5.2 By service provider
6.5.2.1 Healthcare at Home Ltd
6.5.2.1.1 Company overview
6.5.2.1.2 Financial performance
6.5.2.1.3 Service benchmarking
6.5.2.1.4 Strategic initiatives
6.5.2.2 Bayada Home Health Care
6.5.2.2.1 Company overview
6.5.2.2.2 Financial performance
6.5.2.2.3 Service benchmarking
6.5.2.2.4 Strategic initiatives
6.5.2.3 Ashfield Healthcare
6.5.2.3.1 Company overview
6.5.2.3.2 Financial performance
6.5.2.4.3 Service benchmarking
6.5.2.4.4 Strategic initiatives
6.5.2.4 Accredo Health Group, Inc.
6.5.2.4.1 Company overview
6.5.2.4.2 Financial performance
6.5.2.4.3 Service benchmarking
6.5.2.4.4 Strategic initiatives
6.5.2.5 Heritage Independent Living Ltd
6.5.2.5.1 Company overview
6.5.2.5.2 Financial performance
6.5.2.5.3 Service benchmarking
6.5.2.5.4 Strategic initiatives
6.5.2.6 Mears Group PLC
6.5.2.6.1 Company overview
6.5.2.6.2 Financial performance
6.5.2.6.3 Service benchmarking
6.5.2.6.4 Strategic initiatives
Chapter 7 Methodology and Scope
7.1 Estimates and Forecast Timeline
7.2 Research Methodology
7.3 Information Procurement
7.3.1 Purchased Database
7.3.2 GVR’s Internal Database
7.3.3 Secondary Sources
7.3.4 Primary Research
7.4 Information or Data Analysis
7.4.1 Data Analysis Models
7.5 Market Formulation & Validation
7.6 Model Details
7.6.1 Volume price analysis
7.7 List of Secondary Sources
7.8 List of Abbreviations
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers